Optimized diagnosis of neuroborreliosis using signaling protein as a biomarker

Credit: Erik Karits from Pexels A newly defined threshold for the concentration of the cytokine CXCL13 may improve the diagnosis of neuroborreliosis. The clinical diagnosis of this disease, which is caused by infections from tick bites, is still difficult and often occurs long after infection. CXCL13 now makes it possible to diagnose neuroborreliosis more quickly and start treatment earlier. In the new study conducted by the Karl Landsteiner University of Health Sciences (KL Krems) and published in the Journal of Central Nervous System Disease, a concentration of CXCL13 in the Read More

Related posts:

  1. Research confirms circZFR is a promising biomarker for colorectal cancer diagnosis and prognosis
  2. Study reveals novel immune-based biomarker helps detect ovarian cancer years before conventional diagnosis
  3. Study reveals CREB3’s role in hepatocellular carcinoma suppression via AKT signaling
  4. Researchers identify unknown signaling pathway in the brain responsible for migraine with aura
  5. Signaling pathway in brain helps maintain balance in microglia, prevent cognitive deficit
  6. Researchers identify a novel biomarker linked to renal cancer recurrence
  7. New biomarker identified for predicting adverse events of tuberculosis therapy
  8. Researchers discover a new neural biomarker for obsessive-compulsive disorder

Leave a Reply

Your email address will not be published. Required fields are marked *